References
- Andrews-Hanna, J. R., Smallwood, J., & Spreng, R. N. (2014). The default network and self- generated thought: Component processes, dynamic control, and clinical relevance. Annals of the New York Academy of Sciences, 1316, 29–52. doi:10.1111/nyas.12360
- Ashburner, J., Barnes, G., Chen, C., Daunizeau, J., Flandin, G., Friston, K., … Moran, R., (2014). SPM12 Manual. London (United Kingdom): Wellcome Trust Centre for Neuroimaging.
- Aubin, H. J., Rollema, H., Svensson, T. H., & Winterer, G. (2012). Smoking, quitting, and psychiatric disease: A review. Neuroscience & Biobehavioral Reviews, 36(1), 271–284. doi:10.1016/j.neubiorev.2011.06.007
- Barr, R. S., Culhane, M. A., Jubelt, L. E., Mufti, R. S., Dyer, M. A., Weiss, A. P., … Evins, A. E. (2008). The effects of transdermal nicotine on cognition in nonsmokers with schizophrenia and nonpsychiatric controls. Neuropsychopharmacology, 33(3), 480–490. doi:10.1038/sj.npp.1301423
- Bartra, O., McGuire, J. T., & Kable, J. W. (2013). The valuation system: A coordinate-based meta-analysis of BOLD fMRI experiments examining neural correlates of subjective value. NeuroImage, 76, 412–427. doi:10.1016/j.neuroimage.2013.02.063
- Beck, A. T., Steer, R. A., & Brown, G. K. (1966). Manual for the Beck Depression Inventory-II. San Antonio, TX: Psychological Corporation.
- Behzadi, Y., Restom, K., Liau, J., & Liu, T. T. (2007). A component based noise correction method (CompCor) for BOLD and perfusion based fMRI. Neuroimage, 37(1), 90–101. doi:10.1016/j.neuroimage.2007.04.042
- Berlin, I., Singleton, E. G., & Heishman, S. J. (2010). Validity of the 12-item french version of the tobacco craving questionnaire in treatment-seeking smokers. Nicotine & Tobacco Research, 12(5), 500–507. doi:10.1093/ntr/ntq039
- Chai, X. J., Nieto-Castanon, A., Ongur, D., & Whitfield-Gabrieli, S. (2012). Anticorrelations in resting state networks without global signal regression. Neuroimage, 59(2), 1420–1428. doi:10.1016/j.neuroimage.2011.08.048
- Courtney, K. E., Ghahremani, D. G., London, E. D., & Ray, L. A. (2014). The association between cue-reactivity in the precuneus and level of dependence on nicotine and alcohol. Drug and Alcohol Dependence, 141, 21–26. doi:10.1016/j.drugalcdep.2014.04.026
- de Leon, J., & Diaz, F. J. (2005). A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors. Schizophrenia Research, 76(2–3), 135–157. doi:10.1016/j.schres.2005.02.010
- Dong, D., Wang, Y., Chang, X., Luo, C., & Yao, D. (2018). Dysfunction of large-scale brain networks in schizophrenia: A meta-analysis of resting-state functional connectivity. Schizophrenia Bulletin, 44(1), 168–181. doi:10.1093/schbul/sbx034
- Engelmann, J. M., Versace, F., Robinson, J. D., Minnix, J. A., Lam, C. Y., Cui, Y., … Cinciripini, P. M. (2012). Neural substrates of smoking cue reactivity: A meta-analysis of fMRI studies, NeuroImage, 60(1), 252–262. doi:10.1016/j.neuroimage.2011.12.024
- Fagerstrom, K. O., Schneider, N. G. (1989). Measuring nicotine dependence: A review of the Fagerstrom Tolerance Questionnaire. Journal of Behavioral Medecine, 12, 2. doi:10.1007/BF00846549
- Fischer, A. S., Whitfield-Gabrieli, S., Roth, R. M., Brunette, M. F., & Green, A. I. (2014). Impaired functional connectivity of brain reward circuitry in patients with schizophrenia and cannabis use disorder: Effects of cannabis and THC. Schizophrenia Research, 158(1–3), 176–82. doi:10.1016/j.schres.2014.04.033
- Friston, K. J., Buechel, C., Fink, G. R., Morris, J., Rolls, E., Dolan, R. J. (1997). Psychophysiological and modulatory interactions in neuroimaging. Neuroimage, 6(3), 218–229. doi:10.1006/nimg.1997.0291
- Gilbert, D. G. & Rabinovich, N.E. (1999). International smoking image series (with neutral counterparts): Version 1.2. Southern Illinois University: Cardondale, Illinois, USA.
- Howes, O. D., Kambeitz, J., Kim, E., Stahl, D., Slifstein, M., Abi-Dargham, A., Kapur, S. (2012). The nature of dopamine dysfunction in schizophrenia and what this means for treatment. Archives General Psychiatry, 69(8), 776–786. doi:10.1001/archgenpsychiatry.2012.169
- Kay, S. R., Fiszbein, A., & Opler, L.A. (1987). The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophrenia Bulletin, 13(2), 261–276. doi:10.1093/schbul/13.2.261
- Kelly, D. L., McMahon, R. P., Wehring, H. J., Liu, F., Mackowick, K. M., Boggs, D. L., … Dixon, L. (2011). Cigarette smoking and mortality risk in people with schizophrenia. Schizophrenia Bulletin, 37(4), 832–838. doi:10.1093/schbul/sbp152
- Khokhar, J. Y., Dwiel, L. L., Henricks, A. M., Doucette, W. T., & Green, A. I. (2018) The link between schizophrenia and substance use disorder: A unifying hypothesis. Schizophrenia Research, 194, 78–85. doi:10.1016/j.schres.2017.04.016
- Krystal, J. H., D'Souza, D. C., Gallinat, J., Driesen, N., Abi-Dargham, A., Petrakis, I., … Pearlson, G. (2006). The vulnerability to alcohol and substance abuse in individuals diagnosed with schizophrenia. Neurotoxicity Research, 10(3–4), 235–252. doi:10.1007/BF03033360
- Lang, P. J., Bradley, M. M., & Cuthbert, B. N. (2008). International affective picture system (IAPS): Affective ratings of pictures and instruction manual. Technical Report A-8. Gainesville, FL: University of Florida.
- Lo, S., Heishman, S. J., Raley, H., Wright, K., Wehring, H. J., Moolchan, E. T., … Kelly, D. L. (2011). Tobacco craving in smokers with and without schizophrenia. Schizophrenia Research, 127(1–3), 241–245. doi:10.1016/j.schres.2010.06.017
- McClernon, F. J., Kozink, R. V., & Rose, J. E. (2008). Individual differences in nicotine dependence, withdrawal symptoms, and sex predict transient fMRI-BOLD responses to smoking cues. Neuropsychopharmacology, 33(9), 2148–2157. doi:10.1038/sj.npp.1301618
- Michael, B., Spitzer, R. L., Giggon, M., & Williams, J. B. W. (2002). Structured Clinical Interview for DSM-IV-TR Axis I disorders, Nonpatient edition (SCID-I/NP). New York: Biometrics Research.
- Mohamed, S., Rosenheck, R. A., Lin, H., Swartz, M., McEvoy, J. P., Stroup, S. (2015). Randomized trial of the effect of four second-generation antipsychotics and one first-generation antipsychotic on cigarette smoking, alcohol, and drug use in chronic schizophrenia. The Journal of Nervous and Mental Disease, 203(7), 486–492. doi:10.1097/NMD.0000000000000317
- Potvin, S., Tikasz, A., Dinh-Williams, L., Bourque, J., & Mendrek, A. (2015). Cigarette cravings, impulsivity, and the brain. Frontiers in Psychiatry, 6, 125. doi:10.3389/fpsyt.2015.00125
- Prochaska, J. J., Hall, S. M., & Bero, L. A. (2008). Tobacco use among individuals with schizophrenia: What role has the tobacco industry played? Schizophrenia Bulletin, 34(3), 555–567. doi:10.1093/schbul/sbm117
- Seeman, P. (2002). Atypical antipsychotics: mechanism of action. The Canadian Journal of Psychiatry, 47(1), 27–38. doi:10.1177/070674370204700106
- Weinberger, A. H., McKee, S. A., & George, T. P. (2012) Smoking cue reactivity in adult smokers with and without depression: A pilot study. The American Journal on Addictions, 21(2), 136–144. doi:10.1111/j.1521-0391.2011.00203.x
- Whitfield-Gabrieli, S. & Nieto-Castanon, A. (2012) Conn: A functional connectivity toolbox for correlated and anticorrelated brain networks. Brain Connectivity, 2(3), 125–141. doi:10.1089/brain.2012.0073
- Williams, J. M., Gandhi, K. K., Lu, S. E., Kumar, S., Steinberg, M. L., Cottler, B., & Benowitz, N. L. (2011). Shorter interpuff interval is associated with higher nicotine intake in smokers with schizophrenia. Drug and Alcohol Dependence, 118(2–3), 313–319. doi:10.1016/j.drugalcdep.2011.04.009
- Wing, V. C., Wass, C. E., Soh, D. W., & George, T. P. (2012). A review of neurobiological vulnerability factors and treatment implications for comorbid tobacco dependence in schizophrenia. Annals of the New York Academy Sciences, 1248, 89–106. doi:10.1111/j.1749-6632.2011.06261.x
- Winterer, G. (2010). Why do patients with schizophrenia smoke? Current Opinion in Psychiatry, 23(2), 112–119. doi:10.1097/YCO.0b013e3283366643
- Woods, S. W. (2003). Chlorpromazine equivalent doses for the newer atypical antipsychotics. Journal of Clinical Psychiatry, 64(6), 663–667. doi:10.4088/JCP.v64n0607
- Zhornitsky, S., Rizkallah, E., Pampoulova, T., Chiasson, J. P., Stip, E., Rompré, P. P., & Potvin, S. (2010). Antipsychotic agents for the treatment of substance use disorders in patients with and without comorbid psychosis. Journal of Clinical Psychopharmacology, 30(4), 417–424. doi:10.1097/JCP.0b013e3181e7810a